| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 15 | 2024 | 532 | 3.060 |
Why?
|
| STAT3 Transcription Factor | 8 | 2021 | 216 | 1.940 |
Why?
|
| STAT5 Transcription Factor | 3 | 2021 | 89 | 1.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2021 | 96 | 0.970 |
Why?
|
| Apoptosis | 8 | 2020 | 1787 | 0.810 |
Why?
|
| Antineoplastic Agents | 7 | 2023 | 1664 | 0.770 |
Why?
|
| Interleukin-10 | 1 | 2022 | 172 | 0.740 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 312 | 0.650 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2024 | 61 | 0.620 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 470 | 0.600 |
Why?
|
| Gene Rearrangement | 3 | 2016 | 320 | 0.530 |
Why?
|
| Transcriptome | 3 | 2021 | 903 | 0.530 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2015 | 5 | 0.500 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 713 | 0.500 |
Why?
|
| Mitoxantrone | 1 | 2015 | 27 | 0.500 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 576 | 0.480 |
Why?
|
| Methyltransferases | 2 | 2016 | 71 | 0.470 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 211 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 553 | 0.400 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2023 | 99 | 0.370 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 668 | 0.360 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3286 | 0.330 |
Why?
|
| Signal Transduction | 4 | 2019 | 4498 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 667 | 0.310 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2000 | 22 | 0.300 |
Why?
|
| Naphthalenes | 2 | 2020 | 37 | 0.300 |
Why?
|
| Recurrence | 2 | 2022 | 1419 | 0.290 |
Why?
|
| Myelopoiesis | 1 | 2007 | 13 | 0.290 |
Why?
|
| Child, Preschool | 12 | 2024 | 13927 | 0.280 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 153 | 0.280 |
Why?
|
| Child | 16 | 2024 | 24262 | 0.280 |
Why?
|
| Myeloid Cells | 1 | 2007 | 99 | 0.270 |
Why?
|
| Infant | 10 | 2024 | 12370 | 0.270 |
Why?
|
| Interleukin-6 | 2 | 2022 | 410 | 0.260 |
Why?
|
| Sulfonamides | 2 | 2020 | 259 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2021 | 862 | 0.250 |
Why?
|
| Hippocampus | 7 | 1996 | 819 | 0.250 |
Why?
|
| Adolescent | 13 | 2024 | 19126 | 0.250 |
Why?
|
| Neutrophils | 1 | 2007 | 372 | 0.240 |
Why?
|
| Candida tropicalis | 1 | 2024 | 16 | 0.230 |
Why?
|
| Candidiasis, Invasive | 1 | 2024 | 19 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 197 | 0.230 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 11 | 0.220 |
Why?
|
| Translocation, Genetic | 2 | 2018 | 351 | 0.220 |
Why?
|
| Prognosis | 5 | 2024 | 4518 | 0.220 |
Why?
|
| Immunophenotyping | 1 | 2024 | 328 | 0.220 |
Why?
|
| Benzeneacetamides | 3 | 2000 | 8 | 0.210 |
Why?
|
| Quinolines | 1 | 2023 | 95 | 0.210 |
Why?
|
| Antifungal Agents | 1 | 2024 | 286 | 0.200 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 263 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 64 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1915 | 0.190 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 79 | 0.190 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 286 | 0.190 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 66 | 0.180 |
Why?
|
| Interleukin-13 | 1 | 2021 | 96 | 0.180 |
Why?
|
| Cryopreservation | 1 | 2021 | 82 | 0.180 |
Why?
|
| Humans | 26 | 2024 | 123280 | 0.180 |
Why?
|
| Male | 22 | 2024 | 60345 | 0.170 |
Why?
|
| Atovaquone | 1 | 2019 | 8 | 0.170 |
Why?
|
| Dentate Gyrus | 3 | 2000 | 53 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 524 | 0.170 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 1304 | 0.170 |
Why?
|
| Pyrrolidines | 3 | 2000 | 36 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 12 | 0.170 |
Why?
|
| Interleukin-15 | 1 | 2020 | 91 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 93 | 0.160 |
Why?
|
| Guinea Pigs | 7 | 2000 | 166 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 482 | 0.160 |
Why?
|
| Cytokines | 2 | 2022 | 1266 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 374 | 0.150 |
Why?
|
| Dihydroergotamine | 1 | 2018 | 10 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2018 | 33 | 0.150 |
Why?
|
| Phosphorylation | 2 | 2012 | 1613 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 78 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 85 | 0.150 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 163 | 0.150 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 286 | 0.140 |
Why?
|
| Female | 14 | 2024 | 65628 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1414 | 0.140 |
Why?
|
| Dynorphins | 3 | 2000 | 9 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 534 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 137 | 0.140 |
Why?
|
| Animals | 22 | 2020 | 33850 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 182 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2024 | 804 | 0.140 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 8 | 0.130 |
Why?
|
| Rhodium | 1 | 2015 | 4 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2016 | 38 | 0.130 |
Why?
|
| Cell Proliferation | 5 | 2018 | 2297 | 0.130 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 28 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2015 | 12 | 0.120 |
Why?
|
| Cell Survival | 3 | 2019 | 805 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 378 | 0.120 |
Why?
|
| Young Adult | 3 | 2021 | 8870 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 1201 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2016 | 1102 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 858 | 0.120 |
Why?
|
| Synapses | 2 | 2000 | 447 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 884 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2005 | 2591 | 0.120 |
Why?
|
| HL-60 Cells | 1 | 2014 | 31 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1682 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 1063 | 0.110 |
Why?
|
| Histones | 2 | 2016 | 528 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 824 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 24 | 0.110 |
Why?
|
| Synaptic Transmission | 2 | 1997 | 348 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 1994 | 105 | 0.110 |
Why?
|
| Endorphins | 2 | 1994 | 7 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 296 | 0.110 |
Why?
|
| Mice | 10 | 2020 | 17555 | 0.110 |
Why?
|
| Filgrastim | 1 | 2012 | 15 | 0.110 |
Why?
|
| Leukemia | 1 | 2016 | 375 | 0.100 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 60 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1289 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 230 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2018 | 570 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2012 | 134 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 618 | 0.090 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 146 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2016 | 661 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 542 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 717 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 513 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1871 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 291 | 0.090 |
Why?
|
| Nerve Fibers | 2 | 2000 | 72 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 533 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 294 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2007 | 409 | 0.080 |
Why?
|
| Axons | 3 | 2000 | 380 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1385 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1473 | 0.080 |
Why?
|
| Neurons | 3 | 2000 | 1935 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 805 | 0.070 |
Why?
|
| Dendrites | 2 | 2000 | 183 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 94 | 0.070 |
Why?
|
| Pilocarpine | 1 | 1997 | 12 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1693 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 212 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 1996 | 8 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 29091 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 569 | 0.070 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 84 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4299 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 177 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 1996 | 76 | 0.060 |
Why?
|
| Potassium Channels | 1 | 1996 | 158 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 2771 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 19 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 280 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 10033 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 674 | 0.060 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 75 | 0.060 |
Why?
|
| Drug Resistance, Fungal | 1 | 2024 | 24 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 98 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2816 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2005 | 92 | 0.060 |
Why?
|
| Calcium Channels | 1 | 1995 | 159 | 0.060 |
Why?
|
| Granulocytes | 1 | 1994 | 65 | 0.060 |
Why?
|
| Karyotyping | 2 | 2015 | 330 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2058 | 0.060 |
Why?
|
| Aniline Compounds | 1 | 2023 | 19 | 0.060 |
Why?
|
| Drug Design | 1 | 2005 | 146 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 1994 | 145 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 1994 | 200 | 0.050 |
Why?
|
| Nitriles | 1 | 2023 | 146 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 756 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2005 | 457 | 0.050 |
Why?
|
| Norepinephrine | 1 | 1992 | 174 | 0.050 |
Why?
|
| Analgesics | 3 | 2000 | 134 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 782 | 0.050 |
Why?
|
| Learning | 1 | 1995 | 361 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 2000 | 967 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 1991 | 75 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2005 | 808 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1991 | 122 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 804 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 444 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 182 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 1268 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8116 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1690 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 351 | 0.040 |
Why?
|
| Brain | 2 | 1995 | 2964 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 122 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 3055 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1069 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 16081 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2018 | 275 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 37 | 0.030 |
Why?
|
| Kinetics | 3 | 2007 | 1317 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 2053 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 25 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 11 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 49 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2016 | 84 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1741 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 194 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 295 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 239 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 226 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 221 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 208 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 125 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 262 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 155 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 284 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 198 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 289 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1996 | 139 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 391 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 1010 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 42 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1996 | 202 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 664 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 528 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 159 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 1291 | 0.030 |
Why?
|
| DNA | 1 | 2018 | 1596 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2016 | 939 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 790 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1251 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 538 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3734 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 371 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 507 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1686 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1990 | 14 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2000 | 14 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 3668 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 59 | 0.020 |
Why?
|
| Calcium | 2 | 1995 | 1098 | 0.020 |
Why?
|
| Mutation | 2 | 2015 | 5765 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12176 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 136 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 233 | 0.020 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1996 | 6 | 0.020 |
Why?
|
| Bee Venoms | 1 | 1996 | 7 | 0.020 |
Why?
|
| Nerve Endings | 1 | 1996 | 8 | 0.020 |
Why?
|
| Tetraethylammonium | 1 | 1996 | 9 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 32 | 0.020 |
Why?
|
| Barium | 1 | 1996 | 17 | 0.020 |
Why?
|
| Glyburide | 1 | 1996 | 22 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1996 | 27 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1996 | 122 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 392 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1996 | 56 | 0.020 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1995 | 7 | 0.020 |
Why?
|
| Isradipine | 1 | 1995 | 7 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 753 | 0.020 |
Why?
|
| Nifedipine | 1 | 1995 | 20 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 113 | 0.020 |
Why?
|
| Genomic Library | 1 | 1995 | 39 | 0.020 |
Why?
|
| Naltrexone | 1 | 1995 | 69 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1995 | 74 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1995 | 188 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1994 | 21 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 71 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 90 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 54 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 290 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1218 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 810 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 248 | 0.010 |
Why?
|
| Brain Stem | 1 | 1995 | 115 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 383 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 884 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 25 | 0.010 |
Why?
|
| Naloxone | 1 | 1992 | 46 | 0.010 |
Why?
|
| Propranolol | 1 | 1992 | 128 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 448 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1992 | 316 | 0.010 |
Why?
|
| Cerebellum | 1 | 1995 | 415 | 0.010 |
Why?
|
| Dipeptides | 1 | 1991 | 59 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 261 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1991 | 193 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1991 | 304 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 3045 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 999 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 26095 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 6223 | 0.010 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 1990 | 6 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 68 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 70 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 96 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 65 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1990 | 31 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 63 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 313 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 392 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 422 | 0.010 |
Why?
|